Human Immunodeficiency Virus and Total Joint Arthroplasty: The Risk for Infection Is Reduced

The rates of PJI after TJA in HIV-only patients are lower than those in patients with both HIV and hemophilia. Treatment of patients with HAART and optimization of underlying comorbidities appears to lower the rate of PJI in this patient population.